ACCESS® 2 IMMUNOASSAY SYSTEM
Report
- Report Number
- 2122870-2011-00022
- Event Type
- Malfunction
- Date Received
- January 7, 2011
- Date of Event
- December 10, 2010
- Report Date
- December 10, 2010
- Manufacturer
- BECKMAN COULTER INC.
- Product Code
- MMI
- PMA / PMN Number
- K922823/A007
- Removal / Correction Number
- N/A
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- KY, US
- Reporter Occupation
- OTHER
Narratives
THE ACCUTNI SAMPLE WAS COLLECTED IN A LIHEP PLASMA TUBE. ALL REPEAT TESTING WAS PERFORMED AFTER THE ORIGINAL SAMPLE WAS RE-CENTRIFUGED. THE CUSTOMER STATED TO CUSTOMER TECHNICAL SUPPORT (CTS) THAT THE SAMPLE WAS SLIGHTLY LIPEMIC AND HAD A LAYER OF "HAZE" BETWEEN THE PLASMA AND CELLS. PER THE CUSTOMER SUPPLIED QC CHARTS, ALL FOUR LEVELS OF ACCUTNI QC HAVE BEEN WITHIN THE CUSTOMER'S ESTABLISHED RANGES FOR THE PAST 30 DAYS. PER THE CUSTOMER SUPPLIED DOCUMENTATION, A ROUTINE SYSTEM CHECK WAS PERFORMED ON (B)(6) 2010 WHICH PASSED WITHIN INSTRUMENT SPECIFICATIONS. SERVICE WAS NOT DISPATCHED FOR THIS EVENT AS THE CUSTOMER ONLY WANTED THE ISSUE DOCUMENTED AT THIS TIME.
A CUSTOMER CONTACTED BECKMAN COULTER INC (BCI) IN REGARDS TO OBTAINING AN ERRONEOUSLY ELEVATED TROPONIN (ACCUTNI) RESULT ABOVE THE AMI CUT-OFF FOR ONE PATIENT THAT WAS GENERATED BY THE ACCESS 2 IMMUNOASSAY SYSTEM. THE ERRONEOUS RESULT WAS REPORTED OUT OF THE LABORATORY; HOWEVER SUBSEQUENT TESTING ON THE ORIGINAL INSTRUMENT, AN ALTERNATE INSTRUMENT, AND AN ALTERNATE METHODOLOGY PRODUCED LOWER RESULTS WITHIN THE NORMAL REFERENCE RANGE AND AN AMENDED REPORT WAS ISSUED. THE CUSTOMER DID NOT RECEIVE ANY REPORT OF PATIENT INJURY REQUIRING MEDICAL INTERVENTION OR CHANGE TO PATIENT TREATMENT ATTRIBUTED OR CONNECTED TO THIS EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ACCESS® 2 IMMUNOASSAY SYSTEM | DISCRETE PHOTOMETRIC CHEMISTRY ANALYZER | MMI | BECKMAN COULTER INC. | ACCESS 2 | N/A |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |